Monalizumab Biosimilar - Ultra Low Endotoxin
Product Sizes
1 mg
ICH5017UL-1MG
5 mg
ICH5017UL-5MG
10 mg
ICH5017UL-10MG
25 mg
ICH5017UL-25MG
50 mg
ICH5017UL-50MG
100 mg
ICH5017UL-100MG
About this Product
- SKU:
- ICH5017UL
- Additional Names:
- KLRC1,NKG2A,CD159a,CD94
- Application:
- Cell-based/Functional Assay
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 5 mg/ml
- Extra Details:
- RUO monalizumab is a blocking antibody that prevents the inhibition of CD8+ T cells and NK cell by tumor cells expressing HLA-E. By acting simultaneously on innate and adaptive immunity, monalizumab may re-establish a broad anti-tumor response.
- Formulation:
- Sterile, preservative-free, solution in PBS. BSA and Azide free.
- Immunogen:
- NKG2A
- Isotype:
- IgG4
- Purity:
- >95%
- Purification:
- Protein A/G Purified
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- Detects human CD159a. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Monalizumab.
- Storage Conditions:
- -70[o]C Avoid freeze/thaw cycles., 2-8[o]C
- Supplier:
- ichorbio
- Type:
- Antibody: Biosimilar Antibody
- Shipping Costs:
- Free shipping to UK Customers
- Manufacturer's Data Sheet:https://ichor.bio/productpdf/print/index/url_key/monalizumab-biosimilar-research-grade-ich5017/
